Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

Celltrion Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?

CELLTRION has seventeen approved drugs.

Summary for Celltrion

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	17
Patent Litigation for Celltrion:	See patent lawsuits for Celltrion
PTAB Cases with Celltrion as petitioner:	See PTAB cases with Celltrion as petitioner

Drugs and US Patents for Celltrion

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Celltrion	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	TABLET;ORAL	090073-002	Sep 4, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Celltrion	DEFERASIROX	deferasirox	TABLET;ORAL	212669-002	May 27, 2021	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Celltrion	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	TABLET;ORAL	090073-001	Sep 4, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Celltrion	PREGABALIN	pregabalin	CAPSULE;ORAL	212865-004	Mar 20, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Celltrion	FAMOTIDINE	famotidine	TABLET;ORAL	075786-002	Apr 16, 2001	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Celltrion

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Boehringer Ingelheim

Medtronic

Dow

Mallinckrodt

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.